It is a pharma private limited company based in Cuttack, Orissa, India, established in 2016.
2016 | Cuttack, Orissa, India | ActiveJixon Pharmaceuticals Private Limited, a active private limited company, was established on 04 July 2016 in Cuttack, Orissa, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U33309OR2016PTC025471. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Employing 13 professional, Its leadership includes Surendra Kumar Behera (Director), Rashmi Ranjan Behera (Director). Past directors included Rajesh Kumar Sahoo, Madhusmita Sahoo. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Barik Sahi Sankarpur, Cuttack, Orissa, 753012.
U33309OR2016PTC025471
025471
04 July 2016
₹1.00 M
₹0.15 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Jixon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surendra Kumar Behera | Director | 04 Jul 2016 | Current |
| Rashmi Ranjan Behera | Director | 29 Sep 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jun 2017 | Past |
| Pramod Abcsdd | Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jixon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.24% increase. The company also saw a substantial improvement in profitability, with a 28.83% increase in profit. The company's net worth Soared by an impressive increase of 51.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Jixon Pharmaceuticals had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,001,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2021 | Axis Bank Limited | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Jixon Pharmaceuticals has a workforce of 13 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jixon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jixon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Jixon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Jixon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 1.00 M with Charge ID 100447468 was registered on 17 May 2021. was completed.
Rashmi Ranjan Behera was appointed as a Director was appointed as a Director on 29 Sep 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.
Progress on Surendra Kumar Behera was appointed as a Director was appointed as a Director on 04 Jul 2016 & has been associated with this company since 9 years 5 months . was documented.
Jixon Pharmaceuticals Private Limited was registered on 04 Jul 2016 with Roc Cuttack & aged 9 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Jixon Pharmaceuticals Private Limited is U33309OR2016PTC025471.
Jixon Pharmaceuticals Private Limited is headquartered at Barik Sahi Sankarpur, Cuttack, Orissa, 753012.
Jixon Pharmaceuticals Private Limited was incorporated on 04 July 2016.
The current directors of Jixon Pharmaceuticals Private Limited are
The primary industry of Jixon Pharmaceuticals Private Limited is Pharma.
Jixon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jixon Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
The compliance status of Jixon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX